Will percutaneous interventional treatment for lung cancer cause adverse reactions? Mild pain

The adverse symptoms induced by percutaneous interventional treatment for lung cancer are usually mild pain, which is usually not obvious and can only be felt by the patient when coughing or breathing vigorously.

We know that lung cancer is a dangerous disease that is very harmful and needs to be treated early. So, will percutaneous interventional treatment of lung cancer produce adverse reactions?
Lung cancer is treated with percutaneous intervention, which is a kind of ablation treatment, and is a relatively advanced minimally invasive surgery. During the treatment, the puncture instrument used by the doctor is a puncture needle, so the patient usually does not feel very obvious discomfort, and the induced pain is usually not very obvious.
However, if the patient has some coughing, or the breathing amplitude is very large, it may induce some discomfort. However, as long as the patient can properly control his breathing, the discomfort can be significantly relieved.
Therefore, relatively speaking, adverse reactions caused by percutaneous treatment of lung cancer are relatively rare. Even if they occur occasionally, they are only some adverse symptoms such as pneumothorax and bleeding.
In summary, although some adverse reactions may occur in patients with lung cancer receiving percutaneous treatment, these adverse reactions are not worth mentioning compared to the huge harm caused by lung cancer.